Table 2 Comparisons between TURP-diagnosed PC patients with RP and nRP after PSM
Variables | RP (n = 131) | nRP (n = 131) | P value | ||
|---|---|---|---|---|---|
N | % | N | % | ||
Age (ys.) | 0.08 | ||||
Median | 74.00 | 76.00 | |||
IQR (range) | 67.00–79.00 (53–90) | 66.00–82.00 (47–90) | |||
Race | 0.32 | ||||
White | 104 | 79.4 | 111 | 84.7 | |
Black | 14 | 10.7 | 7 | 5.3 | |
Others | 13 | 9.9 | 12 | 9.2 | |
Missing | 0 | 0 | 1 | 0.8 | |
Marital status | 0.83 | ||||
Married | 87 | 66.4 | 87 | 66.4 | |
Single | 33 | 25.2 | 38 | 29.0 | |
Missing | 11 | 8.4 | 6 | 4.6 | |
Annual income | 0.71 | ||||
< 7, 000$ | 65 | 49.6 | 62 | 47.3 | |
≥ 7,000$ | 66 | 50.4 | 69 | 52.7 | |
Home location | 0.22 | ||||
Big city | 71 | 54.2 | 61 | 46.6 | |
Small city | 60 | 45.8 | 70 | 53.4 | |
Diagnosis year | 1 | ||||
2010–2014 | 49 | 37.4 | 49 | 37.4 | |
2014–2019 | 82 | 62.6 | 82 | 62.6 | |
PSA | < 0.001 | ||||
0.1 or less nanograms/milliliter (ng/ml) | 3 | 2.3 | 0 | 0 | |
Test ordered, results not in the chart | 5 | 3.8 | 6 | 4.6 | |
98.0 ng/ml or greater | 4 | 3.1 | 49 | 37.4 | |
Missing | 119 | 90.8 | 76 | 58.0 | |
Pathological Gleason score | / | ||||
≤ 6 | 61 | 46.6 | / | / | |
7 | 55 | 42.0 | / | ||
8–10 | 15 | 11.5 | / | / | |
Stage | 0.71 | ||||
Localized | 84 | 64.1 | 82 | 62.6 | |
Reginal | 40 | 30.5 | 39 | 29.8 | |
Distant | 7 | 5.3 | 10 | 7.6 | |
Month to treatment (mo.) | 0.20 | ||||
Median | 0.00 | 0.00 | |||
IQR (range) | 0.00–0.00 (0.00–12.00) | 0.00–1.00 (0.00–2.00) | |||
CDS | < 0.001 | ||||
Yes | 1313 | 100 | 59 | 45.0 | |
No | 0 | 0 | 71 | 54.2 | |
Missing | 1 | 0.8 | |||
Lymph node dissection | < 0.001 | ||||
1 to 3 regional lymph nodes removed | 5 | 3.8 | 3 | 2.3 | |
4 or more regional lymph nodes removed | 101 | 77.1 | 1 | 0.8 | |
Biopsy only | 0 | 0 | 10 | 7.6 | |
Missing | 25 | 19.1 | 117 | 89.3 | |
Radiation therapy | 0.64 | ||||
Beam | 1 | 0.8 | 13 | 9.9 | |
Others | 0 | 0 | 3 | 2.3 | |
No/known | 130 | 99.2 | 115 | 87.8 | |
Chemotherapy | 0.58 | ||||
Yes | 6 | 4.6 | 8 | 6.1 | |
No/known | 125 | 95.4 | 123 | 93.9 | |
Systemic therapy | < 0.05 | ||||
In and before surgery | 3 | 2.3 | 2 | 1.5 | |
After surgery | 10 | 7.6 | 23 | 17.6 | |
No/known | 118 | 90.1 | 106 | 80.9 | |
CSM | < 0.001 | ||||
Death | 5 | 3.8 | 32 | 24.4 | |
Alive or other death | 126 | 96.2 | 99 | 75.6 | |
OM | < 0.05 | ||||
Death | 39 | 29.8 | 58 | 44.3 | |
Alive | 92 | 70.2 | 73 | 55.7 | |
Survival time (mo.) | 0.32 | ||||
Median | 28.00 | 24.00 | |||
IQR (range) | 12.00–54.00 (1-119) | 10.00–49.00 (1-105) | |||